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Editorial on the Research Topic
Glial Cells, Maladaptive Plasticity, and Neurodegeneration: Mechanisms, Targeted Therapies,
and Future Directions
Understanding the biological complexity of the central nervous system (CNS) is a frontier
in neuroscience. Morphological organization of the CNS represents the basis for its
functional properties underlying higher brain functions; therefore, efforts are needed to
boost the comprehension of the organization of the CNS, from the ultrastructural to the
functional-networks level.
To date, two highly integrated and interconnected cellular networks substantiate the anatomo-
functional organization of CNS: neurons and non-neuronal cells, namely glial cells.
Glial cells, including astrocytes, oligodendrocytes, and microglia, actively participate in many
complex functions within the CNS (immunity surveillance and inflammatory response, metabolic
and synaptic homeostasis, modulation of blood-brain barrier—BBB) (Volterra and Meldolesi,
2005). Moreover, interaction with the elements of the extracellular matrix (ECM), an active player
for long-term plasticity and circuit maintenance, adds another level of complexity to the modern
model of the synapse structure (tetrapartite synapse) (Song and Dityatev, 2018). Therefore, if on
one hand glial cells allow adaptive synaptic plasticity of CNS in several physiological conditions
modulating synaptic transmission, homeostasis, and neural pathways signaling, then on the other,
when activated, they boost inflammatory response and perturb neuroglial interactions, synaptic
circuitry, and plasticity. This new condition, called maladaptive synaptic plasticity, may represent
an early stage of neuroinflammatory processes in neurodegenerative disorders (Papa et al., 2014).
Recently, it has been hypothesized that the morpho-functional heterogeneity of astrocytes in
different brain regions might explain the regional diversity of astrocytic response to an external
injury and the selectivity of neuronal degeneration (Cragnolini et al., 2018, 2020). Therefore,
the comprehension of these mechanisms is relevant for the development of targeted therapies
for clinical management of neurodegenerative disorders. Only through unraveling the complex
interactions between the different cell types at the synapse, we will truly understand synaptic
plasticity, higher brain functions, and how perturbations of these interactions contribute to brain
diseases with dramatic clinical impact.
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This Research Topic aims to address the role of neuroglia in
health and disease through a collection of 12 articles that include
two mini-reviews, two reviews, one hypothesis and theory, and
seven original research articles, providing an overview on a broad
spectrum of molecular and cellular bases of glial function in
normal and pathological CNS.
New mechanisms were explored in glial transmission,
signaling, and neural circuitry. It has been established that
astrocytes which release neurotransmitters such as glutamate
and GABA, express a variety of neurotransmitter receptors
and participate in synaptic transmission (Araque et al., 2014).
Furthermore, GABA released from interneurons participates in
astrocyte-mediated control of excitatory synaptic transmission
(Perea et al., 2016) through activation of astrocytic GABA-B
receptors leading to gliotransmission (Liu et al., 2018b). The
coupling between GABA interneuron, astrocytic terminals and
pre/post synaptic compartments may underpin both seizure-
like activity and neuronal synchrony across different brain
regions (Liu et al.). Evidence has also demonstrated that
early neuroinflammation, macrophage infiltration, and astrocytic
activation have a main role in epileptogenesis (Rossi et al.,
2013, 2017). In particular, experimental epileptic seizures after
stroke, brain injury, or pilocarpine administration induce the
release of small intracellular molecules (called DAMP—damage
associated molecular patterns) including the ubiquitous High
Mobility Group Box 1 (HMGB1) nuclear protein (Braun
et al., 2017). It has been proposed that microglial-astroglial
cooperation is required for astrocytes to respond to HMGB-1
and to induce neurodegeneration. Disruption of this HMGB-
1 mediated signaling pathway shows beneficial effects by
reducing neuroinflammation and neurodegeneration after status
epilepticus (Rosciszewski et al.).
Furthermore, thrombin increase in the brain after stroke as a
result of brain-blood barrier breakdown or brain tissue intrinsic
production enhances PAR1-mediated NMDA receptor activity
and increases intracellular calcium levels (Maggio et al., 2013).
Altman et al. reviews the events that lead to a hyperexcitable state
and to maladaptive plasticity that in turn, through an astrocytic
mediated response, synchronize neuronal activity producing
epileptic activity.
Astrocytic functions and activity are also affected by general
anesthetics (Thrane et al., 2012; Liu et al., 2016), particularly the
NMDA antagonist ketamine have an inhibitory role in astrocytic
glutamatergic transmission blocking GluN1/GluN2B receptors.
The decrease of astrocyte-mediated slow inward current (SICs)
synchronization due to ketamine administration at clinical
concentrationmay have serious implications for the development
of dissociative cognitive impairment during ketamine anesthesia
(Zhang et al.). In addition, anesthesia and surgical stress may
cause postoperative cognitive dysfunction (POCD), a highly
prevalent condition in elderly patients undergoing major surgery
or non-invasive procedures under sedation (Leslie, 2017; Skvarc
et al., 2018). Wei et al. hypothesized that mtROS/NLRP3
inflammasome may be part of the upstream pathway mediating
the cleavage and release of the microglial interleukin 1 beta into
brain areas including hippocampus that might play a pivotal role
in POCD.
Besides their role in neural circuitry and signaling, glial
cells are also involved in axonal regeneration and nerve repair.
Ganglionic satellite glial cells (SGCs) create a structural unit
inside the dorsal root ganglion, providing protection against
inflammation, structural, and metabolic support to neurons
(Hanani, 2005). Slit1 is one of the signaling factors that guides
both axon projection and neuronal migration (Blockus and
Chédotal, 2016), by mediating the branching of the sensory
axon growth cone. Evidence has demonstrated that peripheral
nerve injury activates the purinergic system via P2X7 receptors
(mainly expressed on SGCs) and upregulates the expression of
slit1, promoting axonal repair, and regeneration (Zhang et al.).
The relevance of astrocytes to the neurodegenerative process
was highlighted in an experimental model of Parkinson’s disease
(PD). Astrocytes express the α7 nicotinic acetylcholine receptor
(α7nAChR) (Xu et al., 2019) for anti-inflammatory (Egea et al.,
2015), antiapoptotic (Kim et al., 2012), and neuroprotective
functions in health and disease (Liu et al., 2015; Quik et al., 2015).
The α7nAChR agonist PNU-282987 showed neuroprotective
effects in astrocytes treated with 1-methyl-4-phenylpyridinium
(MPP+), reducing the number of degenerating cells, and
alleviating MPP -induced apoptosis. Moreover, PNU-282987
upregulated the expression of the antiapoptotic protein Bcl-2 and
downregulated the expression of the apoptotic protein Bax and
cleaved caspase-3, mainly via the JNK-p53-caspase-3 signaling
(Hua et al.).
The immunological aspects of glial cells were explored by
Zhou et al. in a murine model of experimental autoimmune
encephalomyelitis (EAE). CD73, an astrocytic membrane
ectonucleotidase, quickly converts adenosine monophosphate
(AMP) to adenosine (an anti-inflammatory mediator) that
interacts with ARA1 receptors controlling excitability, synaptic
transmission in brain circuits and neuroinflammation (Liu
et al., 2018a). Upon EAE induction, astrocytes lose most of
their membrane-localized CD73, thus inhibiting the generation
of adenosine in the local microenvironment, boosting the
inflammatory process, and facilitating the pathogenesis of EAE
(Zhou et al.).
Among the inflammatory disorders of the CNS, neuromyelitis
optica spectrum disorder (NMOSD) represents a prototype
of antigen-antibody-induced damage (the disease target is the
aquaporin-4 (AQP4), a water channel protein expressed on
astrocytic end-feet) (Wingerchuk et al., 2015). As in many
other CNS disorders, glutamatergic excitotoxicity may play an
important role in NMOSD (Zekeridou and Lennon, 2015). Da
Silva et al. reviews the pathway that causes AQP4-IgG/AQP4
complex to downregulate the astrocytic glutamate transporter
EAAT2 (Yang et al., 2016), leading to the excitotoxic damage.
Activation of glial cells, dysfunction of the endocannabinoid
signaling and increased expression of pro-inflammatory factors
might also contribute to pathogenesis of autism spectrum
disorder (ASD) (Bronzuoli et al., 2018). Using the ASD animal
model consisting in prenatal exposure to valproic acid (VPA)
(Melancia et al., 2018), it has been demonstrated that an
inflammatory reaction and astrocytic/microglia activation
restricted to the hippocampus and related to impaired
social interactions, stereotypic repetitive behaviors, and
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learning and memory defects. Interestingly, treatment with the
phytocannabinoid cannabidivarin (CBDV) restores hippocampal
endocannabinoid signaling and neuroinflammation induced by
prenatal VPA exposure and recovered social impairments, social
novelty preference, short-term memory deficits, and repetitive
behaviors (Zamberletti et al.).
Connexins and pannexins are widely expressed in glial cells,
where they play several roles including channel and non-channel
functions. These functions include modulation of synaptic gain,
the control of excitability through regulation of the ion and
neurotransmitter composition of the extracellular milieu and the
promotion of neuronal survival (Abudara et al., 2018). Brocardo
et al. review how glial connexins and pannexins are remodeled in
different pathological conditions with variable outcomes in the
context of a neurodegenerative disease.
The established role of glial cells in many neurological
and neuropsychiatric disorders has boosted new glial-targeted
therapies, however the unavailability of validated biomarkers
to assess and monitor gliosis in vivo has limited their clinical
application (Garden and Campbell, 2016). Cavaliere et al. present
a comprehensive overview on molecular neuroimaging, using
positron emission tomography (PET) and magnetic resonance
imaging (MRI) and offer a wide panel of non- or minimally
invasive techniques to image glial targets.
Altogether, this Research Topic has provided an update on
recent developments in glial biology, with many translational
insights for a wider understanding of the neural mechanisms in
health and disease.
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